Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_assertion type Assertion NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_head.
- NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_assertion description "[These include germline DNA single-nucleotide polymorphisms in the BRCA1 and -2 genes to determine high risk in unaffected women, selected tissue-based markers to determine prognosis and predict benefit from therapy, and circulating MUC1, CEA and perhaps tumor cells to monitor patients with metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_provenance.
- NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_assertion evidence source_evidence_literature NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_provenance.
- NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_assertion SIO_000772 24422569 NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_provenance.
- NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_assertion wasDerivedFrom befree-20150227 NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_provenance.
- NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_assertion wasGeneratedBy ECO_0000203 NP270833.RAWn4psLPAnY-f5aCzfNNyIvdiV9n3rPIJEE-YTPuHIuY130_provenance.